Corporate & Investor Presentation

There is a need for end-to-end solutions for COPD patients Global population of COPD patients: ~380 million¹ Self-management (smoking cessation, diet, exercise) Inhaled Pharmaceuticals for COPD 75% of pop. Stage II Increasing severity of disease COPD progression Stage I 21 - updated © 2020 ResMed | Corporate & Investor Presentation Adele Det Glob Health 2015 Oxygen Ventilation 20% of pop. <1% of pop. Stage III Stage IV ResMed

View entire presentation